📅 2026 Update: Advances in Mesothelioma Treatment and Legal Insights

Since the original article was published, there have been significant advancements in mesothelioma treatment options, particularly concerning the use of immunotherapy. New FDA approvals and updated guidelines reflect the evolving landscape of care for patients facing this challenging disease. The earlier article continues further down the page for those seeking foundational information.

🩺 FDA Approvals of New Treatments

In September 2024, the FDA approved Keytruda® (pembrolizumab) in combination with pemetrexed and platinum chemotherapy as a first-line treatment for unresectable advanced or metastatic pleural mesothelioma. This approval was based on the KEYNOTE-483 clinical trial, which showed that this combination therapy results in a median overall survival of 17.3 months compared to 16.1 months for chemotherapy alone.

💊 Combination Therapy Approval

Additionally, the FDA approved Opdivo® (nivolumab) and Yervoy® (ipilimumab) combined as a first-line treatment for inoperable malignant pleural mesothelioma in 2024. The CheckMate 743 trial indicated that patients receiving this combination had a median overall survival of 18.1 months, compared to 14.1 months for those on chemotherapy alone.

🏥 Updated NCCN Guidelines

The National Comprehensive Cancer Network (NCCN) released updated guidelines for 2026, recommending pleurectomy/decortication (P/D) over extrapleural pneumonectomy (EPP) for pleural mesothelioma. EPP is now reserved for rare cases, and surgery is not listed as an option for stage 2 through stage 4 pleural mesothelioma of any cell type.

💰 Costs of New Treatments

As of October 2026, the average wholesale price (AWP) for Keytruda® is approximately $10,000 per 100 mg vial. The costs of Opdivo® and Yervoy® are about $7,000 and $1,200 per vial, respectively. Treatment costs will vary based on dosage, frequency, and insurance coverage.

📌 Key Takeaways

  • FDA approved Keytruda® and the Opdivo® and Yervoy® combination for mesothelioma.
  • Median overall survival rates have improved with these treatments.
  • NCCN now recommends P/D over EPP in most cases.
  • Treatment costs vary and depend on individual circumstances.
  • Ongoing research continues to shape treatment options for mesothelioma.

💡 Tips for Navigating Mesothelioma Treatment Options

Reviewing the details of your own situation with your attorney is crucial for understanding your options effectively.

🏥 Understand Treatment Options

Be aware of the latest FDA-approved treatments for pleural mesothelioma. Keytruda® and the combination of Opdivo® and Yervoy® are leading immunotherapy options that have shown promising survival rates.

📅 Check NCCN Guidelines

Stay updated with the NCCN 2026 guidelines. These guidelines provide essential information on recommended treatments and can help you discuss the best options with your healthcare team.

💰 Assess Treatment Costs

Be prepared for costs associated with your treatment. The average wholesale prices for new therapies can be high, so understanding your insurance coverage is vital for managing expenses effectively.

🏆 Explore Clinical Trials

Investigating ongoing clinical trials can offer access to cutting-edge treatments. Discuss potential participation with your healthcare provider to see if you qualify for any studies that align with your treatment goals.

🤝 Utilize Support Resources

Reach out to organizations like the Mesothelioma Applied Research Foundation or the National Cancer Institute for support. They offer valuable information on treatments and clinical trials, helping you navigate your options better.

🏆 Free Options Ranked by User Reviews (2026)

No national paid services have met the review threshold for this topic, so this section focuses on free government and nonprofit resources available to assist those affected by mesothelioma.

🥇 1. Mesothelioma Applied Research Foundation

This nonprofit organization provides resources and support for patients battling mesothelioma. They offer guidance on treatment options, access to clinical trials, and financial assistance programs. Their aim is to improve the quality of life for patients and their families through education and support.

🥈 2. National Cancer Institute (NCI)

The NCI offers comprehensive resources on mesothelioma, including treatment options and clinical trial information. Their website serves as an educational platform, providing detailed guides for patients and families, along with contact information for further assistance.

🥉 3. National Comprehensive Cancer Network (NCCN)

While NCCN primarily provides treatment guidelines, they also offer resources for patients to understand their diagnosis. Their guidelines are regularly updated, ensuring patients and healthcare providers have access to the latest recommendations for mesothelioma care.

4️⃣ Cancer Support Community

This organization provides support groups and educational resources for cancer patients. They offer emotional support, information on treatment options, and connections to local resources that can help patients navigate their cancer journey.

5️⃣ American Cancer Society (ACS)

The ACS offers information on cancer treatment and support services. They provide resources for patients dealing with mesothelioma, including guidance on navigating insurance, accessing clinical trials, and finding local support groups.

🔎 Things to Check Before Paying for Help

  • 🕵️‍♂️ Verify the legitimacy of any organization or service offering assistance.
  • 📋 Ensure they provide clear information about their services and fees.
  • 📞 Contact them directly to ask questions about their resources.
  • 🏆 Look for reviews or testimonials from other patients and families.
  • 📚 Research their experience and credibility in mesothelioma cases.

❓ Frequently Asked Questions

❔ What is pemetrexed used for in mesothelioma treatment?

Pemetrexed is a standard chemotherapy drug often used in combination with cisplatin or carboplatin for treating pleural mesothelioma. It aims to improve patient outcomes and is often part of a multimodal treatment approach.

🧪 Are there new clinical trials for mesothelioma?

Yes, ongoing clinical trials are essential for advancing mesothelioma treatment. Patients should discuss potential participation with their healthcare providers to access innovative therapies that could enhance their treatment options.

🩺 How have treatment guidelines changed for mesothelioma?

The NCCN has updated its guidelines for 2026, recommending pleurectomy/decortication over extrapleural pneumonectomy for most cases. Surgery is no longer recommended for stage 2 through stage 4 pleural mesothelioma.

💵 How can I manage the costs of mesothelioma treatment?

Understanding your insurance coverage and exploring financial assistance programs from organizations like the Mesothelioma Applied Research Foundation can help manage treatment costs effectively.

🎗️ What support resources are available for mesothelioma patients?

Organizations such as the Mesothelioma Applied Research Foundation and the National Cancer Institute provide valuable resources, including information on treatment options, support groups, and access to clinical trials.

🌍 Can I access new therapies through clinical trials?

Yes, many new therapies are only available through clinical trials. Discussing potential participation with your healthcare provider can provide access to cutting-edge treatments and contribute to medical research.

⚖️ Recent Court Rulings Related to Mesothelioma Cases

Recent court rulings have addressed various aspects of mesothelioma claims, particularly regarding asbestos exposure and compensation for affected individuals. These rulings are crucial for understanding the legal landscape surrounding mesothelioma.

For more insights, browse recent rulings in the news section.

End of October 2026 Update






 



What is Pemetrexed?



Pemetrexed is a chemotherapy drug marketed and manufactured by the Eli Lilly Company. The drug is primarily used to combat Pleural Mesothelioma cancer and other forms of non-small cell lung cancers. 

Pemetrexed


The molecular body of Pemetrexed was developed by Edward Taylor at Princeton University. The drug was clinically developed by Eli Lilly and Company in 2004. The drug is used for the treatment of breast cancer, mesothelioma cancer, pancreatic cancer, non-small cell lung cancers, malignant mesothelioma and colon cancer. 



Pemetrexed is chemically constructed like folic acid; the drug is classified as a folate antimetabolite chemotherapy drug. The drug works by inhibiting three enzymes utilized in pyrimidine and purine synthesis (thymidylate synthase, glycinamide ribonucloetide formyltransferase and dihydrofolate reductase). By inhibiting the formation of pyrimidine nucleotides and precursor purines, Pemetrexed prevents the formation of RNA and DNA, which are both required for the survival and growth of both cancer cells and normal cells. 



In the winter of 2004, the United States Food and Drug Administration approved Pemetrexed for treatment of malignant pleural mesothelioma cancer—a type of cancerous tumor that is located in the lining of the lungs. The FDA approved Pemetrexed to fight malignant mesothelioma only as a combined effort with cisplatin. In September of 2008, The Food and Drug Administration approved Pemetrexed as a first-line treatment—once again only in conjunction with cisplatin—to combat locally-advanced and metastatic non-small cell lung cancers for patients with non-squamous histology. A clinical phase III study revealed benefits of maintenance use of Pemetrexed for non-squamos patients. Currently, the drug is undergoing clinical trials to be used against esophagus cancer and other diseases the mouth area. 



Pemetrexed is recommended in conjunction with carboplatin for a first-line treatment method of advanced forms of non-small cell lung cancers. That being said, the efficacy or toxicity of Pemetrexed with cisplatin compared to Pemetrexed with carboplatin has yet to be established beyond what is typically though about carboplatin or cisplatin drug therapy. 



Side Effects of Pemetrexed:



Whether administered by itself or in combination with cisplatin, Pemetrexed yields the following side effects:



• Patient will experience decreased blood cell counts, as documented by a Complete Blood Count.



• Patient will experience Sleepiness and Mental fatigue. These side effects may be reduced through an Off-label prescription of Provigil. 



• Explosive Diarrhea



• Vomiting and Nausea. Pemetrexed possesses an emetogenic effect that may be managed with prophylactic antiemetics



• Patient will experience mouth, throat or lip blisters/sores. Oral ulcers may be mitigated by strong oral hygeiene practices, including rinsing/washing of the mouth with salt water following any consumption of drink or food



• Patient will experience a severe loss of appetite



• Skin rash is common with Pemetrexed. Doctor-prescribed steroids that are administered the day before or the day of infusion of Pemetrexed is typically applied to avoid these side effects



• Patient will experience significant constipation 



• Low platelets, which will increase your chance of bleeding



• Low white blood cells, which give you a greater chance of developing an infection. If this mesothelioma treatment gives way to a fever above 100.4 degrees you must call your doctor immediately. 



• Pemetrexed decreases your red blood cell count. Low red blood cells will make you get tired easily, make you appear pale and decrease your stamina. 



Pemetrexed and Mesothelioma Cancer:



When Pemetrexed is applied through an IV or orally the drug is commonly referred to by its Trademark name—ALIMTA; both forms of the drug are used to treat malignant pleural mesothelioma cancer. This disease, which affects the inside lining of the chest cavity, is mitigated when ALIMTA is combined with cisplatin—an anti-cancer medicine that is applied when extraction surgery is not an option.  



Pleural mesothelioma cancer is a rare disease that forms from the transformation of cells in the abdominal cavity, the chest cavity and the cavity surrounding your heart. These cells protect your organs by producing a lubricating fluid that enables your organs to freely move around. For instance, these fluids make it easier for your lungs to move inside your chest during everyday breathing.



The tissues formed by the aforementioned cells are referred to as the mesothelium. Malignant tumors of the mesothelium give way to mesothelioma cancer. Approximately 3 out of every 4 mesothelioma patients have their infection start in their chest cavity (known as pleural mesothelioma). 



The primary risk associated with the development of pleural mesothelioma is asbestos exposure. Malignant mesothelioma, in all cases, is rare, with an estimated 2,000 to 3,000 new cases developing each year in the states. Mesothelioma incidences; however, have slowly decreased since the early 1990s. This decrease is widely due to increased safety efforts taken by companies and state governments to limit asbestos exposure. 



More than 50% of mesothelioma patients have pain in the side of their lower back or chest. The majority of mesothelioma patients will report shortness of breath, while fewer will exhibit weight loss, cough, fever, sweating, trouble swallowing, explosive diarrhea and fatigue. Other symptoms associated with malignant mesothelioma cancer include: swelling of the face and arms, muscle weakness and hoarseness. The majority of mesothelioma patients will exhibit symptoms a few months before they are formally diagnosed. If you have ever been exposed to asbestos and have these symptoms, you must see a medical professional as soon as possible.